Sign In
Buy HCAT
$2.09
+0.0100 (+0.481%)
At Close: Jul 31, 2026
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of “Hold” by Brokerages
01:32am, Tuesday, 30'th Dec 2025
Shares of Health Catalyst, Inc. (NASDAQ: HCAT - Get Free Report) have been assigned a consensus rating of "Hold" from the fourteen research firms that are currently covering the company, MarketBeat re
Contrasting Health Catalyst (NASDAQ:HCAT) & Precipio (NASDAQ:PRPO)
01:46am, Thursday, 25'th Dec 2025
Health Catalyst (NASDAQ: HCAT - Get Free Report) and Precipio (NASDAQ: PRPO - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two compan
HeartSciences (NASDAQ:HSCS) & Health Catalyst (NASDAQ:HCAT) Critical Analysis
02:14am, Sunday, 21'st Dec 2025
HeartSciences (NASDAQ: HSCS - Get Free Report) and Health Catalyst (NASDAQ: HCAT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two bu
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
06:59am, Tuesday, 02'nd Dec 2025
SALT LAKE CITY , Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare
Health Catalyst to Participate in Upcoming Investor Conferences
04:14pm, Friday, 14'th Nov 2025
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
Acadian Asset Management LLC Has $4.39 Million Stake in Health Catalyst, Inc. $HCAT
03:16am, Friday, 14'th Nov 2025
Acadian Asset Management LLC lifted its holdings in shares of Health Catalyst, Inc. (NASDAQ: HCAT) by 25.1% in the undefined quarter, according to its most recent filing with the Securities and Exchan
Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call Transcript
10:31pm, Monday, 10'th Nov 2025
Health Catalyst, Inc. ( HCAT ) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Matt Hopper Daniel Burton - CEO & Director Benjamin Albert - President & COO Jason Alger - Chief
Health Catalyst (HCAT) Q3 Earnings and Revenues Top Estimates
07:55pm, Monday, 10'th Nov 2025
Health Catalyst (HCAT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.07 per share a year ago.
Health Catalyst (HCAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
07:55pm, Monday, 10'th Nov 2025
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Str
Health Catalyst Achieves HITRUST r2 Certification, Demonstrating the Highest Level of Information Protection Assurance
04:03pm, Monday, 10'th Nov 2025
SALT LAKE CITY , Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
UnityPoint Health to Unlock Next Phase of Analytics Innovation by Activating Health Catalyst Ignite™
04:03pm, Monday, 10'th Nov 2025
SALT LAKE CITY , Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to
Health Catalyst Reports Third Quarter 2025 Results
04:03pm, Monday, 10'th Nov 2025
SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizati
Health Catalyst (HCAT) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:16am, Thursday, 06'th Nov 2025
Besides Wall Street's top-and-bottom-line estimates for Health Catalyst (HCAT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during
Impax Small Cap Fund Q3 2025 Contributors And Detractors
04:26pm, Tuesday, 28'th Oct 2025
Ligand Pharmaceuticals (LGND) (Health Care, Pharmaceuticals) shares rose after announcing adjusted earnings per share that came in ahead of consensus. Acadian Asset Management (AAMI) (Financials, Asse
Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025
04:18pm, Monday, 20'th Oct 2025
SALT LAKE CITY, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
